XML 81 R71.htm IDEA: XBRL DOCUMENT v3.22.2
Segment Data (Schedule of Net Sales from External Customers by Products) (Details) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended 6 Months Ended
Jul. 01, 2022
Jun. 16, 2022
Jun. 25, 2021
Jun. 16, 2022
Jun. 25, 2021
Segment Reporting Information          
Net sales $ 85.0 $ 383.7 $ 546.4 $ 874.6 $ 1,104.4
Specialty Brands | Operating Segments          
Segment Reporting Information          
Net sales 58.2 247.7 381.5 587.1 789.9
Specialty Generics          
Segment Reporting Information          
Net sales 26.8 136.0 164.9 287.5 314.5
Specialty Generics | Operating Segments          
Segment Reporting Information          
Net sales 26.8 136.0 164.9 287.5 314.5
Acthar | Specialty Brands          
Segment Reporting Information          
Net sales 27.5 94.2 151.5 221.9 280.5
Inomax | Specialty Brands          
Segment Reporting Information          
Net sales 13.5 66.8 105.9 165.8 239.9
Ofirmev | Specialty Brands          
Segment Reporting Information          
Net sales (0.2) (0.1) 6.5 2.5 19.3
Therakos immunotherapy | Specialty Brands          
Segment Reporting Information          
Net sales 10.2 49.7 68.5 109.6 135.3
Amitiza [Member] | Specialty Brands          
Segment Reporting Information          
Net sales 5.8 [1] 33.8 44.8 [1] 81.5 106.2 [1]
Other | Specialty Brands          
Segment Reporting Information          
Net sales 1.4 3.3 4.3 5.8 8.7
Opioids | Specialty Generics          
Segment Reporting Information          
Net sales 8.7 38.8 53.8 88.8 108.5
ADHD | Specialty Generics          
Segment Reporting Information          
Net sales 1.8 6.8 7.8 17.5 16.1
Addiction Treatment | Specialty Generics          
Segment Reporting Information          
Net sales 2.5 14.1 16.0 30.0 32.4
Other Generics | Specialty Generics          
Segment Reporting Information          
Net sales 0.1 2.0 3.6 4.9 5.5
Generics | Specialty Generics          
Segment Reporting Information          
Net sales 13.1 61.7 81.2 141.2 162.5
Controlled substances | Specialty Generics          
Segment Reporting Information          
Net sales 1.7 17.2 25.6 37.6 43.0
APAP | Specialty Generics          
Segment Reporting Information          
Net sales 11.3 50.2 51.7 96.5 97.2
Other API | Specialty Generics          
Segment Reporting Information          
Net sales 0.7 6.9 6.4 12.2 11.8
API | Specialty Generics          
Segment Reporting Information          
Net sales $ 13.7 $ 74.3 $ 83.7 $ 146.3 $ 152.0
[1] Amitiza consists of both product net sales and royalties. Refer to Note 4 for further details on Amitiza's revenues.